APA (7th ed.) Citation

Uemura, M., Kanazawa, M., Yamagishi, T., Nagai, T., Takahashi, M., Koide, S., . . . Onodera, O. (2020). Role of RNF213 p.4810K variant in the development of intracranial arterial disease in patients treated with nilotinib. Journal of the Neurological Sciences, 408, N.PAG. https://doi.org/10.1016/j.jns.2019.116577

Chicago Style (17th ed.) Citation

Uemura, Masahiro, et al. "Role of RNF213 P.4810K Variant in the Development of Intracranial Arterial Disease in Patients Treated with Nilotinib." Journal of the Neurological Sciences 408 (2020): N.PAG. https://doi.org/10.1016/j.jns.2019.116577.

MLA (9th ed.) Citation

Uemura, Masahiro, et al. "Role of RNF213 P.4810K Variant in the Development of Intracranial Arterial Disease in Patients Treated with Nilotinib." Journal of the Neurological Sciences, vol. 408, 2020, p. N.PAG, https://doi.org/10.1016/j.jns.2019.116577.